Cleared Traditional

K162208 - DxC 700 AU Clinical Chemistry Analyzer, AU IgG Reagent (FDA 510(k) Clearance)

Jan 2017
Decision
157d
Days
Class 2
Risk

K162208 is an FDA 510(k) clearance for the DxC 700 AU Clinical Chemistry Analyzer, AU IgG Reagent. This device is classified as a Method, Nephelometric, Immunoglobulins (g, A, M) (Class II - Special Controls, product code CFN).

Submitted by Beckman Coulter, Inc. (Brea, US). The FDA issued a Cleared decision on January 9, 2017, 157 days after receiving the submission on August 5, 2016.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5510.

Submission Details

510(k) Number K162208 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 05, 2016
Decision Date January 09, 2017
Days to Decision 157 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code CFN — Method, Nephelometric, Immunoglobulins (g, A, M)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5510